Application of three­dimensional speckle tracking in evaluating left atrial function damage in lung cancer patients after immunotherapy

doi:10.3877/cma.j.issn.1674-6902.2025.05.030

Abstract

Caikun Li, Youhong Zhang, Binbin Xiao. Application of threedimensional speckle tracking in evaluating left atrial function damage in lung cancer patients after immunotherapy[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(05): 821-823.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfbjbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6902.2025.05.030

https://zhfbjbzz.cma-cmc.com.cn/EN/Y2025/V18/I05/821

Figures/Tables 2

References 26

1	李慧慧，梁斐，曾剑. ⅠB~ⅢA期可切除非小细胞肺癌辅助化疗后序贯阿替利珠单抗对比最佳支持治疗：IMpower010研究解读[J]. 肿瘤学杂志，2022, 28(12): 1052-1062.
2	冯雨. 辅助化疗后辅助阿替利珠单抗治疗可提高可切除的ⅠB~ⅢA期非小细胞肺癌的无病生存期[J]. 中华医学杂志，2022, 102(19): 1444-1449.
3	颜博，张然，袁智勇，等. 免疫治疗导致的心脏毒性相关研究进展[J]. 癌症，2023, 42(9): 473-483.
4	Gilon D, Iakobishvili Z, Leibowitz D. The diagnosis and management of immune checkpoint inhibitor cardiovascular toxicity: Myocarditis and beyond[J]. Vaccines (Basel), 2022, 10(2): 304.
5	孙涛. 2023版CSCO肿瘤心脏病学指南中化疗及免疫治疗心脏毒性的更新要点解读[J]. 实用肿瘤杂志，2023, 38(5): 434-439.
6	Goody PR, Zimmer S, Öztürk C, et al. 3D-speckle-tracking echocardiography correlates with cardiovascular magnetic resonance imaging diagnosis of acute myocarditis-An observational study[J]. Int J Cardiol Heart Vasc, 2022, 41: 101081.
7	AL Saikhan L, Park C, Tillin T, et al. Does 3D-speckle tracking echocardiography improve prediction of major cardiovascular events in a multi-ethnic general population? A Southall and Brent Revisited (SABRE) cohort study[J]. PLoS One, 2023, 18(6): e0287173.
8	方慧杰，张鑫，翟玉翠，等. 肾细胞癌患者舒尼替尼治疗前后三维斑点追踪成像参数值变化及对心脏毒性的预警价值[J]. 新疆医科大学学报，2024, 47(6): 854-861.
9	中华医学会肿瘤学分会，中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2022版)[J]. 中华肿瘤杂志，2022, 44(6): 457-490.
10	陈婷婷，杨艳玲，韩好男，等. 免疫治疗时代广泛期小细胞肺癌的放疗进展[J]. 中国肺癌杂志，2025, 28(5): 353-362.
11	刘国强，康朔. 阿替利珠单抗联合标准化疗方案治疗广泛期小细胞肺癌的成本-效用分析[J]. 中国药房，2021, 32(1): 77-81.
12	Lei Sheng, Jing Gao, Qian Xu, 等. 依据驱动基因野生型晚期非小细胞肺癌患者的特定病理学特征选择最佳的一线免疫治疗：一项系统回顾和网状荟萃分析[J]. 中华肿瘤防治杂志，2022, 29(1): 1-14.
13	闫静静，刘韶瑜，葛洪霞，等. 免疫检查点抑制剂相关心肌炎的临床诊治进展[J]. 中国循环杂志，2025, 40(2): 197-202.
14	张晶，秦晓涵，都乐，等. 免疫检查点抑制剂相关非心肌炎心脏毒性的诊疗进展[J]. 临床内科杂志，2023, 40(2): 79-82.
15	李秋月，周彦君，王笑林，等. 肺癌患者免疫治疗相关心脏毒性早期识别及预防的研究进展[J]. 中华现代护理杂志，2024, 30(8): 1116-1120.
16	张燕，安涛，张宇辉，等. 肿瘤免疫治疗相关的心脏毒性特点分析[J]. 中华心力衰竭和心肌病杂志(中英文), 2023, 7(2): 97-102.
17	蔡青青，程蕾蕾. 免疫检查点抑制剂相关心脏毒性研究进展[J]. 中国临床医学，2024, 31(4): 531-536.
18	刘志月，刘梅，黄鹤，等. 实时三维超声心动图及三维斑点追踪技术评估左心室射血分数保留的多发性骨髓瘤患者左心房功能的价值[J]. 临床心血管病杂志，2021, 37(10): 936-942.
19	Li M, Lv Q, Zhang Y, et al. Serial changes of right ventricular function assessed by three-dimensional speckle-tracking echocardiography in clinically well adult heart transplantation patients[J]. Int J Cardiovasc Imag, 2023, 39(4): 725-736.
20	陈婧，张松涛. 4DAutoVQ、3D-STI在老年慢性心力衰竭患者心功能评价中的应用研究[J]. 新疆医科大学学报，2023, 46(1): 86-92.
21	朵天军，朱战英，赵彩虹，等. 3D-STI下左心房功能参数与冠状动脉病变严重程度的相关性[J]. 中南医学科学杂志，2023, 51(6): 946-948.
22	阎琳，唐力，马春燕，等. 二维斑点追踪成像评价蒽环类抗肿瘤药对乳腺癌患者左房功能的影响[J]. 临床超声医学杂志，2014, 16(11): 729-732.
23	王凤霞，陶静，燕建锋，等. 3D-STI在ECMO辅助下复杂冠脉病变患者PCI术前后心功能评估中的应用[J]. 中国医疗设备，2021, 36(5): 91-94.
24	梁帅，赵美娜，王晓辉，等. 超声3D-STI参数联合血清NT-proBNP水平对急性心肌梗死患者PCI术后不良心血管事件的预测价值[J]. 川北医学院学报，2025, 40(6): 751-754.
25	马晓，唐国璋，赵亮，等. 左房扩张指数联合三维斑点追踪技术评价心房颤动的左心房功能[J]. 中国超声医学杂志，2023, 39(5): 519-522.
26	Al Saikhan L, Park C, Tillin T, et al. Does 3D-speckle tracking echocardiography improve prediction of major cardiovascular events in a multi-ethnic general population? A Southall and Brent Revisited (SABRE) cohort study[J]. PLoS One, 2023, 18(6): e0287173.

心功能	治疗前	治疗后	t值	P值
LASs	41.18±2.42	35.20±2.36	13.930	0.000
LASe	－21.78±1.94	－17.25±1.22	15.564	0.000
LASa	－24.30±1.99	－20.26±1.87	11.649	0.000
LAAEF(%)	39.19±3.78	34.35±3.69	7.214	0.000
LAPEF(%)	36.50±3.17	31.84±2.98	8.434	0.000
LATEF(%)	61.63±6.45	55.11±4.64	6.461	0.000
LAVpre	19.69±1.45	21.85±1.66	7.716	0.000
LAVmin	11.96±1.42	14.39±1.02	10.944	0.000
LAVmax	30.63±2.11	31.84±2.66	2.806	0.006
LAAEF(%)	39.19±3.78	34.35±3.69	7.214	0.000
LAPEF(%)	36.50±3.17	31.84±2.98	8.434	0.000
LATEF(%)	61.63±6.45	55.11±4.64	6.461	0.000
LAVpre	19.69±1.45	21.85±1.66	7.716	0.000
LAVmin	11.96±1.42	14.39±1.02	10.944	0.000
LAVmax	30.63±2.11	31.84±2.66	2.806	0.006

心功能	治疗前	治疗后	t值	P值
LASs	41.18±2.42	35.20±2.36	13.930	0.000
LASe	－21.78±1.94	－17.25±1.22	15.564	0.000
LASa	－24.30±1.99	－20.26±1.87	11.649	0.000
LAAEF(%)	39.19±3.78	34.35±3.69	7.214	0.000
LAPEF(%)	36.50±3.17	31.84±2.98	8.434	0.000
LATEF(%)	61.63±6.45	55.11±4.64	6.461	0.000
LAVpre	19.69±1.45	21.85±1.66	7.716	0.000
LAVmin	11.96±1.42	14.39±1.02	10.944	0.000
LAVmax	30.63±2.11	31.84±2.66	2.806	0.006
LAAEF(%)	39.19±3.78	34.35±3.69	7.214	0.000
LAPEF(%)	36.50±3.17	31.84±2.98	8.434	0.000
LATEF(%)	61.63±6.45	55.11±4.64	6.461	0.000
LAVpre	19.69±1.45	21.85±1.66	7.716	0.000
LAVmin	11.96±1.42	14.39±1.02	10.944	0.000
LAVmax	30.63±2.11	31.84±2.66	2.806	0.006

Please choose a citation manager

Content to export

Application of threedimensional speckle tracking in evaluating left atrial function damage in lung cancer patients after immunotherapy

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 26

Related Articles 0

Recommended Articles

Metrics

Comments

模态框（Modal）标题

Please choose a citation manager

Content to export

Application of three­dimensional speckle tracking in evaluating left atrial function damage in lung cancer patients after immunotherapy

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 26

Related Articles 0

Recommended Articles

Metrics

Comments

Application of threedimensional speckle tracking in evaluating left atrial function damage in lung cancer patients after immunotherapy